Ovid Therapeutics Inc. (OVID)

Ovid Therapeutics Stock Forecast

Stock Price Forecast

The 5 analysts with 12-month price forecasts for Ovid Therapeutics stock have an average target of 4.04, with a low estimate of 1.20 and a high estimate of 8.00. The average target predicts an increase of 304.36% from the current stock price of 1.00.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$1.20	$4.04	$3.00	$8.00
Change	+20.11%	+304.36%	+200.27%	+700.72%

Analyst Ratings

The average analyst rating for OVID stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jul '24	Aug '24	Sep '24	Oct '24	Nov '24	Dec '24
Strong Buy	3	3	3	3	3	3
Buy	1	1	1	1	1	1
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	5	5	5	5	5	5

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Raghuram Selvaraju HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $3	Strong Buy	Reiterates	$3	+200.27%	Dec 4, 2024
Raghuram Selvaraju HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $3	Strong Buy	Reiterates	$3	+200.27%	Sep 30, 2024
Raghuram Selvaraju HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $3	Strong Buy	Reiterates	$3	+200.27%	Aug 19, 2024
Raghuram Selvaraju HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $3	Strong Buy	Reiterates	$3	+200.27%	Jul 26, 2024
Raghuram Selvaraju HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $3	Strong Buy	Reiterates	$3	+200.27%	Jul 2, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

671.29K

Increased by 71.38%

from 391.70K

Revenue Next Year

35.21M

Increased by 5,144.81%

from 671.29K

EPS This Year

-0.41

from -0.74

EPS Next Year

-0.31

from -0.41

Fiscal Year	FY 2019	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2019	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	-	12.62M	208.38M	1.50M	391.70K	671.29K	35.21M	27.14M
Revenue Growth	-	-	1,551.57%	-99.28%	-73.93%	71.38%	5,144.81%	-22.91%
EPS	-1.54	-1.39	1.76	-0.77	-0.74	-0.41	-0.31	-0.57
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	10	9	8

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2024	2025	2026	2027	2028	2029
High	1.3M	188.4M	92.9M
Avg	671,293	35.2M	27.1M
Low	480,200	n/a	n/a

Revenue Growth

Revenue Growth	2024	2025	2026	2027	2028	2029
High	221.7%	27,960.8%	163.9%
Avg	71.4%	5,144.8%	-22.9%
Low	22.6%	-	-

EPS Forecast

EPS	2024	2025	2026	2027	2028	2029
High	-0.41	1.47	0.45
Avg	-0.41	-0.31	-0.57
Low	-0.42	-0.71	-1.64

EPS Growth

EPS Growth	2024	2025	2026	2027	2028	2029
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.